Physician profile
Ralph Philosophe
NPI 1649287749
$7,555.50
in general payments reported to CMS, 2019-2025
23 companies · $888 in 2025
The $888 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,747 · 2020: $281 · 2021: $1,011 · 2022: $727 · 2023: $801 · 2024: $101 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,226 · Travel and Lodging: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.16 |
| Travel and Lodging | $563.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,456.09 | 2019-2025 | Altis |
| Medtronic USA, INC. | $1,237.16 | 2019-2020 | |
| Boston Scientific Corporation | $966.15 | 2019-2021 | |
| Medtronic, INC. | $950.97 | 2022-2025 | Interstim |
| Abbvie INC. | $265.27 | 2019-2023 | |
| Minerva Surgical, INC | $251.40 | 2022-2025 | |
| Intuitive Surgical, INC. | $240.18 | 2022 | |
| Axonics, INC. | $231.35 | 2023 | Axonics |
| Sumitomo Pharma America, INC. | $158.61 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $129.99 | 2019-2025 | Veozah |
| Hologic Sales and Service, LLC | $128.92 | 2021 | |
| Amgen INC. | $81.40 | 2019-2025 | Evenity |
| Mayne Pharma Commercial LLC | $75.38 | 2023 | |
| Allergan, INC. | $74.48 | 2019 | |
| Merck Sharp & Dohme LLC | $71.50 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $60.08 | 2021-2022 | |
| Myovant Sciences INC. | $37.89 | 2022 | |
| Therapeuticsmd, INC. | $27.12 | 2019 | |
| Caldera Medical, INC | $26.66 | 2021-2023 | Desara |
| Aspira Women'S Health INC | $26.06 | 2019 | |
| Agile Therapeutics, INC. | $20.79 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.24 | 2023 | |
| Exeltis, USA INC. | $18.81 | 2023 | Solosec |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Philosophe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.